Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly(lactide-co-glycolide) foamspheres

International Journal of Oral and Maxillofacial Surgery

Volumn 31, Issue 1, 2002, Pages 60-65

  Weber, F E ^a,b   Eyrich, G ^a,b   Gratz K W ^a,b   Maly, F E ^c   Sailer, H F ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Mund und Kieferheilkunde   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Bone augmentation; Bone morphogenetic protein; Bone regeneration; Delivery; Hydrogel; Microspheres; Release system

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; CYTOKINE; GELATIN; LACTIC ACID; MICROSPHERE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYLACTIDE; POLYMER; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BIODEGRADABILITY; BIODEGRADABLE IMPLANT; BONE REGENERATION; CALVARIA; CARTILAGE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG IMPLANT; DRUG RELEASE; DRUG SCREENING; HAMSTER; HUMAN; HYDROGEL; MOLECULE; NONHUMAN; OSSIFICATION; RAT; SKULL; CRICETULUS;

ABSORBABLE IMPLANTS; ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; CRICETINAE; CRICETULUS; DRUG EVALUATION, PRECLINICAL; DRUG IMPLANTS; HUMANS; HYDROGEL; LACTIC ACID; MICROSPHERES; POLYGLYCOLIC ACID; POLYMERS; RATS; RECOMBINANT PROTEINS; SKULL;

EID: 0036005924     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1054/ijom.2001.0154     Document Type: Article

References (23)

1. Process for the production of biological active protein (e.g. TGF)
2. Protein delivery from biodegradable microspheres
3. Searching for a novel carrier for bioactive delivery of bone morphogenetic protein
4. Factors for osseous repair and delivery
5. Poly(alpha-hydroxy acid) carrier for delivering recombinant human bone morphogenetic protein-2 for bone regeneration
6. Comparison of bone regeneration in a rabbit skull defect by recombinant human BMP-2 incorporated in biodegradable hydrogel and in solution
7. Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer
8. Bone morphogenetic protein augmentation grafting of resistant femoral non-unions
9. Distal metaphysical nonunion. Deformity and bone loss treated by open reduction, internal fixation and human bone morphogenetic protein (hBMP)
10. Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report
11. Resistant nonunions and partial or complete segmental defects of long bones. Treatment with implants of a composition of human bone morphogenetic protein (BMP) and autolyzed, antigen-extracted, allogeneic (AAA) bone
12. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblast cells by recombinant human bone morphogenetic protein-2
13. Potential applications and delivery strategies for bone morphogenetic proteins
14. Expression of bone morphogenetic proteins (BMPs) in fractured mouse bone tissue: In situ hybridisation with polymerase chain reaction (pcr)-derived antisense DNA probe
15. Number of osteoprogenitor cells in human bone marrow markely decreases after skeletal maturation
16. Application of purified bone morphogenetic protein (BMP) in cranio-maxillo-facial surgery. BMP in compromised surgical reconstructions using titanium implants
17. Application of purified bone morphogenetic protein (BMP) preparations in cranio-maxillofacial surgery. Reconstitutions in craniofacial malformations and post-traumatic or operative defects of skull with lyophilized cartilage and BMP
18. Purified bovine bone morphogenetic protein for clinical use in difficult conditions of cranio-maxillofacial surgery
19. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model
20. Bone: Formation by autoinduction
21. In pre-sterol carrier protein 2 (SCP2) in solution the leader peptide 1-20 is flexibly disordered, and residues 21-143 adopt the same fold as in mature SCP2
22. Novel Regulators of Bone Formation: Molecular Clones and Activities
23. Ectopic bone formation induced by biodegradable hydrogels incorporating bone morphogenetic protein